Back to Journals » Drug Design, Development and Therapy » Volume 9

Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents

Total article views   HTML views PDF downloads Totals
22,771 Dovepress* 17,709+ 2,261 19,970
PubMed Central* 5,062 1,601 6,663
Totals 22,771 3,862 26,633
*Since 7 January 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar